Evogene, DuPont Expand Deal Aimed at Soybean Disease Resistance | GenomeWeb

NEW YORK (GenomeWeb News) – Evogene today announced that it and DuPont Pioneer have extended and expanded their multiyear research collaboration aimed at developing varieties of soybean resistant to Asian Soybean Rust, or ASR.

As part of the expanded deal, novel genes identified by Evogene will be evaluated and validated by DuPont Pioneer, the seed business of DuPont, as possible candidates for further development and commercialization. Evogene's Gene2Product computational platform will be added to the gene discovery program, as well.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.